Search clinical trials for: Pelvic Inflammatory Disease(PID)

Total 116914 results

H. Lee Moffitt Cancer Center and Research Institute
Gateway for Cancer Research

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (Ustekinumab)

Graft vs. Host Disease

United States
Eisai China Inc.

Completed

Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

Lumbar Disc Degenerative Disease

China
Shengjing Hospital

Completed

Positive Node Traced Before Neoadjuvant Chemotherapy (NAC)

Breast Cancer

China
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Wenzhou Medical University; The Affiliated Hospital... and other collaborators

Recruiting

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Multiple Myeloma | Minimal Residual Disease

China
Takeda
Takeda Development Center Americas, Inc.

Not yet recruiting

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire

Completed

A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Primary Immunodeficiency Diseases (PID)

Japan
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

Primary Immunodeficiency Diseases (PID)

Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
Baxalta now part of Shire

Completed

Phase 2/3 Study of IGSC, 20% in PIDD

Primary Immunodeficiency Diseases (PID)

United States, Canada
Baxalta now part of Shire

Completed

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
The First Affiliated Hospital with Nanjing Medical...

Recruiting

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Biliary Tract Cancer

China
Pfizer

Completed

A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee (ITIC)

Osteoarthritis

United States, Argentina, Czech Republic, Slovakia, Spain, Belgium, Canada, Peru, Germany, Hungary, Australia, Italy, Poland, Russian Federation
Children's Hospital Medical Center, Cincinnati

Terminated

Maraviroc as GVHD Prophylaxis in Transplant Recipients

Graft Versus Host Disease (GVHD) | Diagnoses That Require Stem Cell Transplant

United States
Shanghai Children's Medical Center
BioMérieux

Unknown

Clinical Evaluation of the Application of the FilmArray GI Panel in Post-HSCT Diarrhea Patients

GVHD - Graft-Versus-Host Disease
Ology Bioservices

Completed

Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine

Ross River Virus Disease (RRVD)

Netherlands, Austria, Belgium
M.D. Anderson Cancer Center

Active, not recruiting

A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)

Colon Cancer | Resected Stage

United States
Penn State University

Withdrawn

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

Hereditary Angioedema
TaiwanJ Pharmaceuticals Co., Ltd

Not yet recruiting

Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)

Autoimmune Hepatitis
University of Nottingham

Completed

Perspectives on CPPD Outcome Domains

CPPD - Calcium Pyrophosphate Deposition Disease

United Kingdom
Boston Children's Hospital

Recruiting

Gene Discovery Core, The Manton Center

Rare Disorders | Orphan Diseases | Undiagnosed Conditions

United States
University of Iowa

Withdrawn

TP10 Use in Patients With C3 Glomerulopathy (C3G)

Dense Deposit Disease

United States
Bukwang Pharmaceutical

Completed

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

COVID-19

Korea, Republic of
ADMA Biologics, Inc.

Completed

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Primary Immune Deficiency Disorders (PIDD)

United States
Kedrion S.p.A.

Completed

Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)

Primary Immunodeficiency | Hypogammaglobulinemia | Agammaglobulinemia | Antibody Deficiency

United States, Canada
Xenikos
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Terminated

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (2002)

Steroid-Refractory Acute Graft Versus Host Disease

United States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire

Completed

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire

Completed

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

Primary Immunodeficiency Diseases (PID)

United States
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Amyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)

United States
Cumberland Pharmaceuticals

Completed

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Aspirin Exacerbated Respiratory Disease (AERD)

United States
University of Illinois at Chicago
National Institute on Aging (NIA)

Completed

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) | Uncontrolled Diabetes (HBA1c ≥ 10)

United States
New York State Psychiatric Institute
University of Miami; Columbia University; University of Southern California; Feinstein...

Active, not recruiting

Development of Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD)

Healthy Participants

United States
National Cancer Institute (NCI)

Active, not recruiting

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Kaposi Sarcoma

United States
CSL Behring

Completed

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

Primary Immune Deficiency

United States
Assiut University

Not yet recruiting

Impulse Control Disorder Among Parkinson's Disease Patients

Parkinson's Disease
Alexandria University

Completed

Dialysis Recovery Time: Associated Factors and Its Relation to Quality of Life

Dialysis; Complications

Egypt
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Cervical Cancer

United States, Spain, Japan
Assiut University

Not yet recruiting

Evaluation of Cognitive Dysfunction and Psychiatric Comorbidities

Wilson Disease
Assiut University

Not yet recruiting

Celiac Disease Among Egyptian Children With Unexplained Short Stature

Celiac Disease
Shandong University
National Health Medical Data (North Center)

Recruiting

A Lifecourse Map of Diseases in China

Rare Diseases | Common Diseases

China
Assiut University

Unknown

Kienbock Disease Radiographic Guided Treatment Versus Arthroscopic Guided Treatment

Kienbock Disease
Mario Negri Institute for Pharmacological Research

Terminated

Enzyme Replacement Therapy in Fabry Disease

Fabry Disease

Italy
Assiut University

Not yet recruiting

Inflammatory and Degenerative Muscle Disease

Inflammatory Muscle Disease
Assiut University

Recruiting

Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital

Inflammatory Bowel Disease

Egypt
Prof. Arie Levine

Completed

The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's Disease (CDED-AD)

Crohn's Disease

Israel
Assiut University

Unknown

Frequency of Hepatobilliary Manifestations in Patients With Inflammatory Bowel Disease

Hepatobilliary Manifestations in Inflammatory Bowel Disease Patients
Dana-Farber Cancer Institute
Roche-Genentech

Active, not recruiting

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Graft vs. Host Disease

United States
Pfizer

Active, not recruiting

Resolution of Sickle Cell Leg Ulcers With Voxelotor (RESOLVE)

Sickle Cell Disease | Leg Ulcers

Brazil, Nigeria, Kenya
Pfizer

Terminated

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

Sickle Cell Disease

United Kingdom
Jeffrey Browning
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease

Healthy | NASH (Non-Alcoholic Steatohepatitis) | NAFLD (Non-Alcoholic Fatty Liver Disease)

United States

Search clinical trials for: Pelvic Inflammatory Disease(PID)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations